Top Markets
#1 Islamic Coin Islamic Coin +151.39%
#2 Akedo Akedo +72.13%
#3 Glidr Glidr +51.75%
#4 Velvet Velvet +50.79%
#5 DOVU DOVU +48.49%
#6 Cross Cross +35.04%
#7 Black Phoenix Black Phoenix +33.93%
#8 Cap Cap +19.07%
#9 DoubleZero DoubleZero +14.81%
#10 Movement Movement +9.74%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
BBS-Bioactive Bone Substitutes Oyj BBS-Bioactive Bone Substitutes Oyj

BBS-Bioactive Bone Substitutes Oyj

BONEH
Rank in Stocks #39435
BBS-Bioactive Bone Substitutes Oyj operates as a Finnish biomedical technology... BBS-Bioactive Bone Substitutes Oyj operates as a Finnish biomedical technology firm, dedicated to innovating, manufacturing, and commercializing bioactive medical devices and implants for orthopedic surgical applications. The company's key offering, ARTEBONE, is an orthobiological product composed of tricalcium phosphate and a comprehensive spectrum of natural bone proteins. This solution is predominantly used for addressing bone deficiencies and aiding healing processes, especially in extremities such as the foot and ankle. BBS-Bioactive Bone Substitutes Plc commenced operations in 1991 and has its corporate headquarters situated in Oulu, Finland.
Share Price
$0.05828914
Last synced: 2025-03-10
Market Cap
$495.40K
Change (1 day)
-0.02%
Change (1 year)
0.00%
Country
FI
Trade BBS-Bioactive Bone Substitutes Oyj (BONEH)

Category

Healthcare
P/E ratio for BBS-Bioactive Bone Substitutes Oyj (BONEH)
P/E ratio as of 2026 TTM: 0
According to BBS-Bioactive Bone Substitutes Oyj latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for BBS-Bioactive Bone Substitutes Oyj from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 33.99 -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 33.47 -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 21.39 -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 18.84 -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 49.47 -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.